Ketamine for Mental Health w/ Mindbloom founder Dylan Beynon

Dylan Beynon is the Founder & CEO of Mindbloom, a telehealth psychedelic therapy startup. Dylan founded Mindbloom to help people treat mental disorders with clinically back solutions involving ketamine.

This is Dylan’s third startup and he has already raised money from some blue chip investors, including Founders Fund.

Mindbloom is on pace to deliver 100,000+ psychedelic therapy sessions by the end of 2021 and is aiming to climb from 13 to 42 states of operation.

In this episode, Dylan and Aaron discuss finding a Chief Medical Officer, ketamine’s history of use, and Dylan’s vision for a healthier future.

timestamps
00:00 Introduction to Dylan Beynon
00:50 Learning Telemedicine
01:50 Difference Of Mindbloom to other Telemedicine Company
04:30 Strategy of Mindbloom
05:40 Consumer Brand Strategy of Mindbloom
06:10 Convenience of Mindbloom to Clients
07:00 Mindbloom's Medication for Mental Health Crisis
09:30 How does Ketamine works?
12:00 The Reason why it is approved
13:30 Effects of Ketamine
14:20 How did Mindbloom started
20:30 How did Dylan convince other people to start this company
23:55 Dylan Talks about the revenue and funding of Mindbloom
26:25 How do they get their revenue in Mindbloom
28:30 Dylan talks on difficulties of getting licenses for Mindbloom
30:15 Dylan on the Mindbloom's mission.
34:30 Mindbloom as a community for people battling mental health crisis
36:10 Future Plans of Mindbloom